Catalyst Wire Dossier Catalyst Wire Dossier

Ivosidenib

ivosidenib · Agios Pharmaceuticals
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for Ivosidenib, covering 2018-07-24 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients [Phase 2]

See pricing